아시아태평양의 완제(Fill Finish) 제조 : 예측(2030년)-지역별 분석-제품별, 모달리티별, 최종 사용자별

The Asia Pacific fill finish manufacturing market was valued at US$ 1,867.35 million in 2022 and is expected to reach US$ 4,202.36 million by 2030; it is estimated to grow at a CAGR of 10.7% from 2022 to 2030.

Low Business Costs in Emerging Markets Boosts Asia Pacific Fill Finish Manufacturing Market

Many Asian countries are emerging as attractive outsourcing locations for various biopharmaceutical manufacturers across the globe. Low manufacturing and operating costs in China, India, and other countries in Asia are the key factors boosting contract manufacturing. Moreover, recent developments in the biopharmaceutical industry in China and India indicate significant potential for the market. The growing pipelines of biologics and biosimilars are further opening new avenues for the contract manufacturers in APAC. Contract manufacturing mostly benefits early-stage drug innovators owing to lower operational costs. To meet the growing demand, many CMOs are expanding their manufacturing capabilities. For instance, in January 2020, STA Pharmaceutical Co., Ltd-a WuXi AppTec company-opened a new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in China.

Asia Pacific Fill Finish Manufacturing Market Overview

In Asia Pacific, China is the largest market for fill finish manufacturing. The growth of the market is primarily attributed to the rising technological advancements in fill finish manufacturing processes in China, increasing developments by the market players, the biopharmaceutical industry's expansion, and the growing prevalence of chronic diseases. There are more than 500 biological product/biopharmaceutical companies in China. Most of those involved in R&D were established by returnees from abroad or by Western/joint venture companies. Although estimates vary widely, analysts believe that the Chinese government spends more than US$ 600 million annually on biotech R&D through its funding initiatives. China's national and local governments also invest in quasi-venture capital companies that invest in IT enterprises.

The market players are expanding their business through organic and inorganic growth strategies. For instance, WuXi Biologics increased the capacity of prefilled syringes (PFS) to 17 million units yearly in June 2022 by opening its drug product factory in Wuxi, China.

The most recent D.P. facility operated by WuXi Bio, a contract development manufacturing organization (CDMO), is called DP5, and it has an advanced isolator filling line for reliable, continuous filling services. According to the company, this provides PFS with a variety of volume delivery options, including 1.25 mL, 3 mL, 1 mL, and 1 mL.

Asia Pacific Fill Finish Manufacturing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Fill Finish Manufacturing Market Segmentation

The Asia Pacific fill finish manufacturing market is segmented based on product, modality, end user, and country. Based on product, the Asia Pacific fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held a larger market share in 2022. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the Asia Pacific fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held the largest market share in 2022.

By end user, the Asia Pacific fill finish manufacturing market is categorized into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held the largest market share in 2022.

Based on country, the Asia Pacific fill finish manufacturing market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific fill finish manufacturing market share in 2022.

Becton Dickinson and Co, Gerresheimer AG, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Asia Pacific NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc are some of the leading players operating in the Asia Pacific fill finish manufacturing market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Fill Finish Manufacturing Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Asia Pacific Fill Finish Manufacturing Market - Key Industry Dynamics

• 5.1 Fill Finish Manufacturing Market - Key Industry Dynamics
• 5.2 Key Market Drivers
  • 5.2.1 Growing Adoption of Prefilled Syringes for Parenteral Administration
  • 5.2.2 Elevating Demand for Biologics
• 5.3 Key Market Restraints
  • 5.3.1 Complexity in Biologics Manufacturing
• 5.4 Key Market Opportunities
  • 5.4.1 Low Business Costs in Emerging Markets
• 5.5 Key Future Trends
  • 5.5.1 Single-Use Systems for Aseptic Fill Finish
• 5.6 Impact of Drivers and Restraints:

6. Fill Finish Manufacturing Market - Asia Pacific Market Analysis

7. Asia Pacific Fill Finish Manufacturing Market Analysis - Product

• 7.1 Consumables
  • 7.1.1 Overview
  • 7.1.2 Consumables Market, Revenue and Forecast to 2030 (US$ Million)
• 7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Fill Finish Manufacturing Market Analysis - Modality

• 8.1 Recombinant Proteins
  • 8.1.1 Overview
  • 8.1.2 Recombinant Proteins Market, Revenue and Forecast to 2030 (US$ Million)
• 8.2 Monoclonal Antibodies
  • 8.2.1 Overview
  • 8.2.2 Monoclonal Antibodies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.3 Vaccines
  • 8.3.1 Overview
  • 8.3.2 Vaccines Market, Revenue and Forecast to 2030 (US$ Million)
• 8.4 Cell Therapies and Biological Therapies
  • 8.4.1 Overview
  • 8.4.2 Cell Therapies and Biological Therapies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.5 Gene Therapies
  • 8.5.1 Overview
  • 8.5.2 Gene Therapies Market, Revenue and Forecast to 2030 (US$ Million)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Fill Finish Manufacturing Market Analysis - End User

• 9.1 Contract Manufacturing Organizations
  • 9.1.1 Overview
  • 9.1.2 Contract Manufacturing Organizations Market, Revenue and Forecast to 2030 (US$ Million)
• 9.2 Biopharmaceutical Companies
  • 9.2.1 Overview
  • 9.2.2 Biopharmaceutical Companies Market, Revenue and Forecast to 2030 (US$ Million)
• 9.3 Others
  • 9.3.1 Overview
  • 9.3.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Fill Finish Manufacturing Market - Country Analysis

• 10.1 Asia Pacific Fill Finish Manufacturing Market Breakdown, by Country
  • 10.1.1 China
  • 10.1.2 China Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.2.1 China Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.2.1.1 China Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.2.2 China Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.2.3 China Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.3 Japan
    • 10.1.3.1 Japan Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.3.1.1 Japan Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.3.2 Japan Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.3.3 Japan Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.4 India
  • 10.1.5 India Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.5.1 India Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.5.1.1 India Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.5.2 India Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.5.3 India Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.6 Australia
  • 10.1.7 Australia Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.7.1 Australia Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.7.1.1 Australia Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.7.2 Australia Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.7.3 Australia Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.8 South Korea
  • 10.1.9 South Korea Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.9.1 South Korea Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.9.1.1 South Korea Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.9.2 South Korea Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.9.3 South Korea Fill Finish Manufacturing Market Breakdown by End User
  • 10.1.10 Rest of Asia Pacific
  • 10.1.11 Rest of Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts to 2030 (US$ Mn)
    • 10.1.11.1 Rest of Asia Pacific Fill Finish Manufacturing Market Breakdown by Product
      • 10.1.11.1.1 Rest of Asia Pacific Fill Finish Manufacturing Market Breakdown by Consumables
    • 10.1.11.2 Rest of Asia Pacific Fill Finish Manufacturing Market Breakdown by Modality
    • 10.1.11.3 Rest of Asia Pacific Fill Finish Manufacturing Market Breakdown by End User

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Fill Finish Manufacturing Market, 2020-2023
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 IMA Industria Macchine Automatiche SpA
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Nipro Medical Europe NV
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Maquinaria Industrial Dara SL
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 SGD SA
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Optima Packaging Group Gmbh
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 NNE AS
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Product & Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Stevanato Group SpA
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Syntegon Technology GmbH
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 West Pharmaceutical Services Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Gerresheimer AG
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 Schott AG
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments
• 12.12 Becton Dickinson and Co
  • 12.12.1 Key Facts
  • 12.12.2 Business Description
  • 12.12.3 Products and Services
  • 12.12.4 Financial Overview
  • 12.12.5 SWOT Analysis
  • 12.12.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms